Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease
about
Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine BiosynthesisThe great escape: pathogen versus host.Fungal-bacterial interactions and their relevance in health.Antifungal potential of Sideroxylon obtusifolium and Syzygium cumini and their mode of action against Candida albicans.Treatment of Oral Candidiasis Using Photodithazine®- Mediated Photodynamic Therapy In Vivo.Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix.Candida albicans Mycofilms Support Staphylococcus aureus Colonization and Enhances Miconazole Resistance in Dual-Species Interactions.Candida albicans/Staphylococcus aureus Dual-Species Biofilm as a Target for the Combination of Essential Oils and Fluconazole or Mupirocin.Dosage and Dose Schedule Screening of Drug Combinations in Agent-Based Models Reveals Hidden Synergies.Tongue coating frequency and its colonization by yeasts in chronic kidney disease patients.Influence of cancer treatment on the Candida albicans isolated from the oral cavities of cancer patients.Candida albicans Sap6 amyloid regions function in cellular aggregation and zinc binding, and contribute to zinc acquisition.Modulation of Staphylococcus aureus Response to Antimicrobials by the Candida albicans Quorum Sensing Molecule Farnesol.Fungi in the Wound Microbiome.Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.Tipping the Balance: Adaptation in Polymicrobial Environments
P2860
Q27317563-09070C11-1125-476B-8EB3-6DB92D8F5652Q35575832-6DECCDD6-197B-4BFC-B0F7-BDD7703E08C4Q35738043-9437516C-199F-45F6-BE30-882ACECDB891Q35961258-06DEC6FA-E8E1-4C8B-8579-91F30577BDDFQ36038009-004B5828-078E-4D31-9D2F-106B4BCE08D9Q36080619-55CBE00F-AF3C-4367-93B0-6B3287393DCAQ36571953-48131C27-7D4D-458A-86CA-0978C34F9741Q37335095-D7C14F0E-C5D9-437C-9A46-FCC7A2009D26Q38915936-F2A4B093-D8EB-4485-82A7-A106A0442AE7Q40086994-25C19556-2A08-4F5F-92AC-F347E38468DBQ40095650-7153BC13-1A59-4BF6-9AC1-73697EFCC8C9Q40649816-71667DA6-F74E-452A-A480-9D507E2CEBE6Q40882454-E3B944D5-AB61-43C8-9ED8-AC065B243D79Q42220015-7EBC9AFC-6A48-4E92-B1AD-27DB4AA423B7Q46308749-7717A79A-7156-441A-BCD0-AA489A3ED001Q55455094-2C8BDC0D-154D-4895-8C75-8B04AEC2A955Q55511181-709886F0-2DF8-4331-9D82-94A1C5F6DC67Q58723255-A3785138-D6EA-40D8-8EDE-884F710E790C
P2860
Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical implications of oral ...... disseminated bacterial disease
@ast
Clinical implications of oral ...... disseminated bacterial disease
@en
Clinical implications of oral ...... disseminated bacterial disease
@nl
type
label
Clinical implications of oral ...... disseminated bacterial disease
@ast
Clinical implications of oral ...... disseminated bacterial disease
@en
Clinical implications of oral ...... disseminated bacterial disease
@nl
prefLabel
Clinical implications of oral ...... disseminated bacterial disease
@ast
Clinical implications of oral ...... disseminated bacterial disease
@en
Clinical implications of oral ...... disseminated bacterial disease
@nl
P2093
P2860
P356
P1476
Clinical implications of oral ...... disseminated bacterial disease
@en
P2093
Brian M Peters
Eric F Kong
Mark E Shirtliff
Mary Ann Jabra-Rizk
Sona Kucharíková
P2860
P304
P356
10.1128/IAI.02843-14
P407
P577
2014-11-24T00:00:00Z